China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2013  
2/27/2013 6:55:50 AM

HONG KONG, Feb. 26, 2013 -- /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financial results for the third quarter and first nine months of fiscal year 2013, which ended December 31, 2012.